Not applicableStudy completedNCT04276272What this trial is testingD4 Choline Breast PET/CTWho this might be right forHER2-negative Breast CancerER Positive Breast CancerMetastatic Breast Cancer Imperial College London 6
Testing effectiveness (Phase 2)Study completedNCT03395899What this trial is testingPre-operative Immunotherapy Combination Strategies in Breast CancerWho this might be right forBreast CancerEstrogen Receptor-positive Breast Cancer Queen Mary University of London 71
Large-scale testing (Phase 3)Ended earlyNCT00925548What this trial is testingSTRIDE - STimulating Immune Response In aDvanced brEast CancerWho this might be right forBreast Cancer EMD Serono 16
Large-scale testing (Phase 3)Study completedNCT02376985What this trial is testingEvaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCTWho this might be right forBreast Cancer Comprehensive Support Project for Oncology Research 174
Testing effectiveness (Phase 2)Study completedNCT04072952What this trial is testingA Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Arvinas Estrogen Receptor, Inc. 217
Not applicableStudy completedNCT03886389What this trial is testingBreast Cancer Diet Intervention StudyWho this might be right forEarly-stage Breast CancerCarbohydrate EngorgementProliferation+2 more Helse Stavanger HF 80
Early research (Phase 1)Study completedNCT01840488What this trial is testingBN83495 Phase I in Post-menopausal WomenWho this might be right forBreast Cancer Ipsen 50
Not applicableUnknownNCT02627703What this trial is testing(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast CancerWho this might be right forBreast Cancer British Columbia Cancer Agency 80
Large-scale testing (Phase 3)Ended earlyNCT01303679What this trial is testing1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast CancerWho this might be right forFirst Line Metastatic Breast Cancer ARCAGY/ GINECO GROUP 117
Testing effectiveness (Phase 2)WithdrawnNCT01361945What this trial is testingAUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast CancerWho this might be right forBreast CancerMetastatic Breast CancerHER-2 Positive Breast Cancer+1 more Texas Tech University Health Sciences Center, El Paso
Very early researchStudy completedNCT03132467What this trial is testingDurvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast CancerWho this might be right forAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+14 more M.D. Anderson Cancer Center 16
Large-scale testing (Phase 3)Active Not RecruitingNCT06760637What this trial is testingStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic DiseaseWho this might be right forBreast Cancer Pfizer 1,035
Not applicableEnded earlyNCT01409811What this trial is testingBiomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic AcidWho this might be right forEstrogen Receptor-positive Breast CancerInvasive Ductal Breast CarcinomaProgesterone Receptor-positive Breast Cancer+4 more City of Hope Medical Center 9
Not applicableEnded earlyNCT01425294What this trial is testingCollection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg TreatmentWho this might be right forBreast Cancer AstraZeneca 231
Early research (Phase 1)Ended earlyNCT07214662What this trial is testingEvaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast CancerWho this might be right forBreast Cancer Genentech, Inc. 3
Testing effectiveness (Phase 2)UnknownNCT03202862What this trial is testingThe Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast CancerWho this might be right forBreast Neoplasms Fudan University 50
Not applicableUnknownNCT03430024What this trial is testingNuclear Myosin VI - a Therapeutic Target in Breast CancerWho this might be right forBreast Cancer Maidstone & Tunbridge Wells NHS Trust 120
Testing effectiveness (Phase 2)Study completedNCT01625286What this trial is testingInvestigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer PatientsWho this might be right forAdvanced or Metastatic Breast CancerER+ve Advanced or Metastatic Breast Cancer AstraZeneca 148
Large-scale testing (Phase 3)Study completedNCT00963729What this trial is testingChemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By SurgeryWho this might be right forBreast Cancer Imperial College London 756
Testing effectiveness (Phase 2)UnknownNCT00931450What this trial is testingSunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast CancerWho this might be right forBreast Cancer Institut Català d'Oncologia 70